Trends in the prescribing of antidepressants following acute myocardial infarction, 1993-2002

Psychosomatic Medicine

Volumn 67, Issue 6, 2005, Pages 916-920

  Benazon, Nili R ^a   Mamdani, Muhammad M ^b   Coyne, James C ^c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antidepressants; Coronary heart disease; Depression; Myocardial infarction

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

ACUTE HEART INFARCTION; AGED; AGING; ARTICLE; CARDIOTOXICITY; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG INDICATION; DRUG UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; AGE; CANADA; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEART INFARCTION; INSURANCE; MALE; PSYCHOLOGICAL ASPECT; STATISTICS;

AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; ONTARIO; PRESCRIPTIONS, DRUG; SEROTONIN UPTAKE INHIBITORS; UNIVERSAL COVERAGE;

EID: 33645641348     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000188399.80167.aa     Document Type: Article

References (38)

1. Carney RM, Freedland KE, Rich MW, Jaffe AS. Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms. Ann Behav Med 1995;17:142-9.
2. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11.
3. Ariyo AA, Haan MM, Tangen CM, Rutledge J, Cushman M, Dobs A, Furberg CD, for the Cardiovascular Health Study Collaborative Research Group. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 2000;102:1773-9.
4. Everson SA, Goldberg DE, Kaplan GA, Cohen RD, Pukkala E, Tuomilehto J, Salonen JT. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 1996;58:113-21.
5. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. Arch Intern Med 2000;160:1261-8.
6. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998;158:1422-6.
7. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-25.
8. Lane D, Carroll D, Ring C, Beevers G, Lip GY. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001;63:221-30.
9. Mayou RA, Gill D, Thompson DR, Day A, Hicks N, Volmink J, Neil A. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000;62:212-9.
10. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, Fauerbach JA. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001;88:337-41.
11. Denollet J, Sys SU, Brutsaert DL. Personality and mortality after myocardial infarction. Psychosom Med 1995;57:582-91.
12. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
13. Kaufmann MW, Fitzgibbons JP, Sussman EJ, Reed JF, Einfalt JM, Rodgers JK, Fricchione GL. Relation between myocardial infarction, depression, hostility, and death. Am Heart J 1999;138:549-54.
14. Parikh SV, Lin E, Lesage AD. Mental health treatment in Ontario: selected comparisons between the primary care and specialty sectors. Can J Psychiatry 1997;42:929-34.
15. Keller MB, Harrison W, Fawcett JA, Gelenberg A, Hirschfelt RMA, Klein D, Kocsis JH, McCullough JP, Rush AJ, Schatzberg A, Thase ME. Treatment of chronic depression with sertraline and imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol Bull 1995;31:205-12.
16. Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M, Gorman JM, Guthrie D, Marek RG, Maurer TA, Meyer R, Phillips K, Ross J, Schwenk TL, Sharfstein SS, Thase ME, Wyatt RJ. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277:333-40.
17. Roose SP, Glassman AH, Walsh BT, Woodring S, Vital-Herne J. Depression, delusions, and suicide. Am J Psychiatry 1983;140:1159-62.
18. Finkelstein SN, Berndt ER, Greenberg PE. Economics of depression: a summary and review prepared for the National Depressive and Manic-Depressive Association-Sponsored Consensus on the Undertreatment of Depression. Chicago, NDMDA, Jan 17-18, 1996.
19. Anderson IM. Selective serotonin inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000;58:19-36.
20. Martin RM, Hilton SR, Kerry SM, Richards NM. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants. BMJ 1997;314:646-51.
21. Mamdani MM, Parikh SV, Austin PC, Upshur REG. Use of antidepressants among elderly subjects: trends and contributing factors. Am J Psychiatry 2000;157:360-7.
22. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, Krishnan KRR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-709.
23. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obiasmanno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac-Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-8.
24. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter M, Kasey S, Marzec U, Harker LA, Nemeroff CB. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-7.
25. Laghrissi-Thode F, Wagner WR, Pollock PC, Johnson PC, Finkel MS. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997;42:290-5.
26. The ENRICHD Investigators. Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. Am Heart J 2000;139(1 pt 1):1-9.
27. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001;154:854-64.
28. Jackevicius CA, Anderson GM, Leiter L, Tu JV. Use of the statins in patients after acute myocardial infarction: does evidence change practice? Arch Intern Med 2001;161:183-8.
29. Rochon PA, Tu JV, Anderson GM, Gurwitz JH, Clark JP, Lau P, Szalai JP, Sykora K, Naylor CD. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet 2000;356:639-44.
30. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516-20.
31. Berkman LF, Blumenthal J, Burg M, Carney RM, Catelli D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106-16.
32. McGovern PG, Jacobs DR, Shahar E, Arnett DK, Folsom AR, Blackburn H, Luepker RV. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota Heart Survey. Circulation 2001;104:19-24.
33. Lesperance F, Frasure-Smith N. The seduction of death. Psychosom Med 1999;61:18-20.
34. Strik JJMH, Lousberg R, Cheriex EC, Honig A. One-year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. J of Psychosom Med 2004;56:59-66.
35. Patten SB, Beck CA. Underuse of antidepressants. Am J Psychiatry 2003;160:189-90.
36. Unutzer J, Katon W, Callahan CM, Williams JW, Hunkeler E, Harpole L, Hoffing M, Della Penna RD, Hitchcock Noel P, Lin EHB, Tang L, Oishi S. Depression treatment in a sample of 1,801 depressed older adults in primary care. J Am Geriatr Soc 2003;51:505-14.
37. Wells KB, Schoenbaum CD, Unutzer J, Lagomasino I, Rubenstein LV. Quality of care for primary care patients with depression in managed care. Arch Fam Med 1999;8:529-36.
38. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001;58:55-61.